LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 217 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $823,000 | +1.9% | 3,000 | -23.1% | 0.22% | +286.0% |
| Q2 2018 | $808,000 | -14.1% | 3,900 | -31.6% | 0.06% | -16.2% |
| Q1 2018 | $941,000 | +361.3% | 5,700 | +185.0% | 0.07% | +21.4% |
| Q3 2016 | $204,000 | +0.5% | 2,000 | +5.3% | 0.06% | -35.6% |
| Q1 2016 | $203,000 | -30.7% | 1,900 | -34.5% | 0.09% | +20.8% |
| Q2 2015 | $293,000 | +12.3% | 2,900 | -40.8% | 0.07% | -17.2% |
| Q4 2014 | $261,000 | -71.7% | 4,900 | -77.0% | 0.09% | -50.0% |
| Q3 2013 | $922,000 | – | 21,300 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |